Injection intended for adults facing obesity or overweight.
Monjaro (TIRZ/GLP1)
Injection intended for adults facing obesity or overweight.
Monjaro, like other antidiabetic medications, mimics intestinal hormones, whose function is to regulate food consumption, slow gastric digestion, increase feelings of satiety, and promote insulin secretion, an essential hormone in glycemic regulation. What sets Monjaro apart from other similar treatments is its ability to simultaneously activate two receptors involved in regulating blood sugar levels and appetite. This dual action allows for better diabetes control and promotes weight loss, according to Dr. Fannie Lajeunesse-Trempe. Receptors are likened to locks, requiring the right key to send the correct signal to the body, which can be a natural or synthetic hormone, like Monjaro.
Who Can Benefit? In Canada, medications approved for weight loss can be prescribed to individuals with a body mass index (BMI) over 27 and presenting other health issues, or with a BMI over 30. However, Health Canada recommends using them in conjunction with lifestyle changes to achieve results similar to those seen in studies. Dr. Lajeunesse-Trempe emphasizes that medication is not a miracle solution.
Research published in journals such as The Lancet, The New England Journal of Medicine, and the Journal of the American Medical Association has demonstrated average weight losses of around 20% of initial weight in individuals with obesity, with or without type 2 diabetes, and presenting associated complications such as hypertension or cardiovascular problems. In comparison, other medications like Ozempic lead to weight losses around 6.7%, while Wegovy results in losses of about 12.4%. Bariatric surgery can lead to greater weight loss, from 25% to 30%.
Dr. Laurent Biertho believes that Monjaro could, in some cases, replace bariatric surgery, thereby reducing waiting lists, which have lengthened due to the COVID-19 pandemic. However, patients will likely need to take Monjaro long-term to maintain weight loss, requiring medical follow-up and sustainable lifestyle changes.
Although promising, Monjaro can lead to side effects such as digestive disorders, though their intensity varies from patient to patient. Additionally, its effectiveness can vary from individual to individual, and treatment discontinuation can often result in weight regain.
In conclusion, the potential approval of Monjaro by Health Canada represents a step forward in the treatment of obesity, a complex disease with repercussions on physical and mental health.
Monjaro (TIRZ/GLP1)
Is it for me?
- Are you struggling to control your food cravings?
- Is your relationship with food complicated?
- Need help managing your diet better?
- Do you want to lose weight quickly without fasting?
- Are you considering fasting but finding it difficult?
- Do you want to reduce your alcohol consumption but find it challenging?
- Are important events approaching, such as a wedding or a trip, and you want to look your best?
- Are you going on a trip and want to shed a few pounds?
- Do you feel overweight and are looking for motivation to change?
- Do you dislike your reflection in the mirror and need support?
- Have you been leading a sedentary lifestyle for too long?
- Do you not engage in physical activity or sports and feel tired?
- Do you want to get back in shape but need a boost?
- Do you want to feel better about yourself and have more energy?
- Do you feel pressure?
- Is your health not at its best and you want to change that?
- Do you have an unhealthy diet and want to change your habits?
- Do you want fast results?
- Are you ready to commit for 45 days?
- Do you want to lose between 20 and 40 pounds in 45 days?
- Are you familiar with Ozempic?
If you answered yes to one or more of these questions, I have the solution for you!
Lose up to 20% of your body fat
in just 12 weeks with Monjaro.
- Decreases appetite
- Regulates blood sugar
- One injection per week is sufficient
BEFORE USING MONJARO
Before starting treatment with Monjaro, it is crucial to consider certain factors to ensure optimal results and your safety. Before taking Monjaro, please consider the following:
ALLERGIES:
Inform your weight loss clinic or diabetic doctor of any allergies to Monjaro, other medications, or components of the drug.
MEDICAL HISTORY:
Report any kidney, pancreas, or diabetic retinopathy issues or gastrointestinal problems affecting digestion.
PREGNANCY AND BREASTFEEDING:
Discuss your pregnancy plans, current pregnancy, or breastfeeding with your doctor, as Monjaro may have implications.
HOW TO USE MONJARO
Monjaro is an injectable weight-loss solution available in single-use ampoules. Patients can self-administer the medication in the stomach, thighs, or back of the arms. Before injection, it is crucial to choose the right injection site and inject directly into that area. Follow these steps meticulously for correct administration. Typically, Monjaro requires weekly injections for weight loss. Consult a diabetic doctor or healthcare professional to determine the appropriate dose and frequency based on your specific needs.
BENEFITS OF TREATMENT WITH MONJARO
Weight loss can significantly improve your overall health. Monjaro, specially designed to treat obesity, can help you achieve your weight goal. Discover the numerous benefits offered by Monjaro for your weight loss: • Improves blood sugar control • Promotes weight loss • Improves cardiovascular health • Sustained effects • Reduces HbA1c • Improves overall health
STORAGE OF MONJARO
Store Monjaro in the refrigerator, between 2°C and 8°C. Protect it from light by keeping it in its original packaging. Single-use pens can be stored at room temperature for up to 21 days if necessary. Follow storage instructions strictly to maintain the effectiveness of the medication.
PRECAUTIONS AND CONTRAINDICATIONS
Key points to consider for different patient groups: • No dosage adjustment is necessary for patients with liver or kidney insufficiency. • Pregnant or breastfeeding women should avoid Monjaro due to potential risks to the fetus or infant. • Individuals with a history of pancreatitis, kidney disorders, diabetic retinopathy, gastroparesis, or medullary thyroid cancer should exercise caution.
WHO CAN USE MONJARO?
You may be a good candidate for Monjaro if you are overweight, have high cholesterol, high blood pressure, health complications, a BMI over 30, or type 2 diabetes.
SIDE EFFECTS
Monjaro may cause digestive side effects such as diarrhea, nausea, headache, vomiting, stomach upset, constipation, and loss of appetite. Monitor symptoms closely and promptly inform your doctor of any persistent or severe side effects.
EXPECTED RESULTS TIMELINE
Monjaro injections can immediately lower blood sugar. Weight loss results may be noticeable after 8 to 12 weeks. Compared to semaglutide, Monjaro may reach the target weight four weeks earlier. Significant weight loss is typically observed after 28 weeks.
WHO SHOULD AVOID MONJARO?
Monjaro may not be suitable for some individuals, particularly those with specific medical histories or those who are pregnant or breastfeeding. Consult a healthcare professional to determine if Monjaro is appropriate for you.
